S-méthyl - L-cystéine, substrat pour réductase de sulfoxide méthionine a

Non disponible en dehors du Royaume-Uni et de l'Irlande

Biochem/physiol Actions

S-Methyl-L-cysteine (SMLC) is a substrate in the catalytic antioxidant system mediated by methionine sulfoxide reductase A (MSRA). SMLC is naturally present in garlic, cabbage, and turnips and has been studied as a theurapeutic for neurodegenerative diseases including Parkinson′s.When used as a dietary supplement in the Drosphilia model of PD, SMLC increases the efficacy of the MRSA catalytic antioxidant system by providing additional substrate available leading to increased resistance to oxidative stress.

Packaging

5, 25, 100 g in glass bottle